Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
IMPV

Imperva

$55.24

0.14 (0.25%)

13:35
10/11/18
10/11
13:35
10/11/18
13:35
Upgrade
Imperva rating change at JPMorgan »

Imperva upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$55.10

12.07 (28.05%)

08:29
10/11/18
10/11
08:29
10/11/18
08:29
Recommendations
Imperva analyst commentary at DA Davidson »

Imperva price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$55.10

12.07 (28.05%)

08:08
10/11/18
10/11
08:08
10/11/18
08:08
Downgrade
Imperva rating change at Macquarie »

Imperva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$55.10

12.07 (28.05%)

07:35
10/11/18
10/11
07:35
10/11/18
07:35
Upgrade
Imperva rating change  »

Imperva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$55.10

12.07 (28.05%)

06:49
10/11/18
10/11
06:49
10/11/18
06:49
Recommendations
Imperva analyst commentary at RBC Capital »

Imperva price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$55.10

12.07 (28.05%)

06:05
10/11/18
10/11
06:05
10/11/18
06:05
Upgrade
Imperva rating change at Morgan Stanley »

Imperva upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

Wednesday
CVS

CVS Health

$78.92

-0.65 (-0.82%)

, AET

Aetna

$203.66

-0.08 (-0.04%)

16:26
10/10/18
10/10
16:26
10/10/18
16:26
General news
Fly Intel: Wall Street's top stories for Wednesday »

Stocks opened in negative…

CVS

CVS Health

$78.92

-0.65 (-0.82%)

AET

Aetna

$203.66

-0.08 (-0.04%)

AVGO

Broadcom

$232.03

-12.54 (-5.13%)

CA

CA Technologies

$42.97

-1.05 (-2.39%)

TDG

TransDigm

$340.18

-11.2 (-3.19%)

ESL

Esterline

$115.41

26.66 (30.04%)

IMPV

Imperva

$55.10

12.07 (28.05%)

MITK

Mitek Systems

$7.76

1.125 (16.96%)

TSE

Trinseo

$60.32

-15.82 (-20.78%)

DSW

DSW

$28.51

-4.17 (-12.76%)

MYGN

Myriad Genetics

$44.87

1.77 (4.11%)

PFE

Pfizer

$44.52

-0.93 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 10

    Oct

  • 10

    Oct

  • 10

    Oct

  • 11

    Oct

  • 15

    Oct

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

AET

Aetna

$206.46

2.72 (1.34%)

, CVS

CVS Health

$80.24

0.67 (0.84%)

12:04
10/10/18
10/10
12:04
10/10/18
12:04
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AET

Aetna

$206.46

2.72 (1.34%)

CVS

CVS Health

$80.24

0.67 (0.84%)

TDG

TransDigm

$340.75

-10.63 (-3.03%)

ESL

Esterline

$115.11

26.36 (29.70%)

IMPV

Imperva

$55.10

12.07 (28.05%)

CLS

Celestica

$10.23

0.25 (2.51%)

KSS

Kohl's

$72.98

1.53 (2.14%)

ABUS

Arbutus Biopharma

$4.26

-1.77 (-29.35%)

TSE

Trinseo

$63.50

-12.64 (-16.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 15

    Oct

  • 16

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

IMPV

Imperva

$55.13

12.1 (28.12%)

10:40
10/10/18
10/10
10:40
10/10/18
10:40
Recommendations
Imperva analyst commentary at JPMorgan »

Imperva buyout a positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

IMPV

Imperva

$43.03

(0.00%)

09:50
10/10/18
10/10
09:50
10/10/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Imperva 

Imperva trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.